Article

Decitabine combined regimen in the therapy of Blastic plasmacytoid dendritic cell neoplasm: case report

2021-12-12

Abstract excerpt

We enrolled a patient diagnosed with blastic plasmacytoid dendritic cell neoplasm (BPDCN) . We have found that TET2, KRAS and BRAF may be involved in the development of the disease, and the combination therapy of Decitabine (DAC) and Arsenic acid (ASO) may be effective for BPDCN harboring the TET2 mutations.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d57cd482-7a50-53a4-99b4-509a86e89400
DOI: 10.22541/au.163928669.96720796/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Decitabine combined regimen in the therapy of Blastic plasmacytoid dendritic cell neoplasm: case reportDOI 10.22541/au.163928669.96720796/v1Read

Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report.Semantic proximity Read

Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm.Semantic proximity Read

Blastic Plasmacytoid Dendritic Cell Neoplasm With De Novo TET2 and KDM6A Mutations.Semantic proximity Read

TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasmSemantic proximity Read

Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN).Semantic proximity Read

Blastic plasmacytoid dendritic cell neoplasm: A case report and review of the literatureSemantic proximity Read

Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.Semantic proximity Read

Blastic Plasmacytoid Dendritic Cell Neoplasm in Children.Semantic proximity Read

TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.Semantic proximity Read

Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience.Semantic proximity Read

Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.Semantic proximity Read

Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.Semantic proximity Read